Premium
Vitamin D 3 for uncontrolled childhood asthma: A pilot study
Author(s) -
Kerley Conor P.,
Hutchinson Katrina,
Cormican Liam,
Faul John,
Greally Peter,
Coghlan David,
Elnazir Basil
Publication year - 2016
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/pai.12547
Subject(s) - medicine , asthma , vitamin d and neurology , placebo , allergy , vitamin , randomized controlled trial , gastroenterology , immunology , pathology , alternative medicine
Background Observational and mechanistic data suggest a role for vitamin D in childhood asthma. However, subsequent interventional trials have been inconsistent. We aimed to assess the effect of 15 weeks of vitamin D 3 supplementation compared with placebo (PL) in Irish children with asthma. Methods We conducted a double‐blind, randomized, PL‐controlled trial of vitamin D supplementation (2000 IU/day) in 44 urban, Caucasian children at high latitude. Assessments were completed at baseline and after 15 weeks of supplementation. Outcome measures were lung function, subjective asthma control and biochemical parameters of total vitamin D, allergy, immunity, airway inflammation, and systemic inflammation. Finally, parents/guardians completed a weekly diary during the trial. Results There was no significant difference in baseline 25( OH )D levels, but there was a significant increase in median 25( OH )D in the vitamin D 3 group (57.5–105 nmol/l) compared with the PL group (52.5–57.5 nmol/l) (p < 0.0001). There was no significant difference between groups regarding subjective asthma control. Compared with PL, there was a significant decrease in school days missed due to asthma (1 vs. 5 days, p = 0.04) and alkaline phosphatase (−3.4 vs. +16; p = 0.037) in the vitamin D 3 group, but there were no beneficial effects regarding several other secondary end‐points. However, there were non‐significant, advantageous changes in the PL group compared with the vitamin D 3 group in subjective asthma control and lung function, particularly percentage of predicted forced expiratory volume in 1 s (+2.5 vs. −4; p = 0.06). Conclusion Vitamin D 3 supplementation led to a significant increase in serum 25( OH )D and decreased school days missed (p = 0.04), but no other advantageous changes in asthma parameters compared with PL. The potential adverse effect of vitamin D deficiency on growth and the potential negative effect of high serum 25( OH )D on pulmonary function warrant further investigation.